Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L, Heilig CM, Bernardo J, Choudhri S, Grosset JH, Guy E, Guyadeen P, Leus MC, Maltas G, Menzies D, Nuermberger EL, Villarino M, Vernon A, Chaisson RE; Tuberculosis Trials Consortium. Dorman SE, et al. Am J Respir Crit Care Med. 2009 Aug 1;180(3):273-80. doi: 10.1164/rccm.200901-0078OC. Epub 2009 Apr 30. Am J Respir Crit Care Med. 2009. PMID: 19406981 Clinical Trial.
The scope and impact of treatment of latent tuberculosis infection in the United States and Canada.
Sterling TR, Bethel J, Goldberg S, Weinfurter P, Yun L, Horsburgh CR; Tuberculosis Epidemiologic Studies Cosortium. Sterling TR, et al. Am J Respir Crit Care Med. 2006 Apr 15;173(8):927-31. doi: 10.1164/rccm.200510-1563OC. Epub 2006 Jan 19. Am J Respir Crit Care Med. 2006. PMID: 16424442 Clinical Trial.
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.
Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR; International Maternal Pediatric and Adolescents AIDS Clinical Trials Group; Tuberculosis Trials Consortium. Villarino ME, et al. Among authors: goldberg sv. JAMA Pediatr. 2015 Mar;169(3):247-55. doi: 10.1001/jamapediatrics.2014.3158. JAMA Pediatr. 2015. PMID: 25580725 Free PMC article. Clinical Trial.
Expanded geographical distribution of the N family of Mycobacterium tuberculosis strains within the United States.
Milan SJ, Hauge KA, Kurepina NE, Lofy KH, Goldberg SV, Narita M, Nolan CM, McElroy PD, Kreiswirth BN, Cangelosi GA. Milan SJ, et al. J Clin Microbiol. 2004 Mar;42(3):1064-8. doi: 10.1128/jcm.42.3.1064-1068.2004. J Clin Microbiol. 2004. PMID: 15004054 Free PMC article.
Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial.
Moro RN, Sterling TR, Saukkonen J, Vernon A, Horsburgh CR, Chaisson RE, Hamilton CD, Villarino ME, Goldberg S. Moro RN, et al. Int J Tuberc Lung Dis. 2017 Mar 1;21(3):286-296. doi: 10.5588/ijtld.16.0469. Epub 2017 Jan 13. Int J Tuberc Lung Dis. 2017. PMID: 28087928 Free PMC article. Clinical Trial.
Cultural case management of latent tuberculosis infection.
Goldberg SV, Wallace J, Jackson JC, Chaulk CP, Nolan CM. Goldberg SV, et al. Int J Tuberc Lung Dis. 2004 Jan;8(1):76-82. Int J Tuberc Lung Dis. 2004. PMID: 14974749
Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis.
Goldberg SV, Duchin JS, Shields T, Nolan CM. Goldberg SV, et al. Am J Respir Crit Care Med. 1999 Aug;160(2):508-12. doi: 10.1164/ajrccm.160.2.9808039. Am J Respir Crit Care Med. 1999. PMID: 10430721
28 results
Jump to page